Skip to content

CFAR Supplement

The UW/Fred Hutch Center for AIDS Research (CFAR) announces the availability of supplement funding for research projects, see attached announcement for more information. Topics are as follows:

  1. Formative, intervention, and implementation research to explore delivery of long-acting PrEP in populations who may benefit (up to $150,000 direct costs/year)
  2. HIV and co-morbidities: Identification of mechanisms and strategies for optimal care that also reduce disparities (up to $150,000 direct cost/year)
  3. Community-led research topic (up to $150,000 direct costs/year)
  4. CFAR Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI) (up to $100,000 direct costs/year)

Eligibility: Project leaders for all scientific areas of interest (topics #1-3) are restricted to early career investigators who have never received an R01-equivalent, P-series or U-series research grants, and established investigators new to HIV. Post-doctoral fellows are eligible to apply if they will assume a faculty position by the time the supplement project and funding begins. For topic #3: Development of the research plan should be an equal partnership between the supplement PI and the community member. For topic #4: Established investigators can be the project leaders for the CDEIPI topic.

Please read the Announcement closely for specific project restrictions.

Each CFAR is only allowed to submit a total of two applications for topics 1-3 and one application for topic 4 to NIH for consideration, so we are conducting an internal competition. If you are interested in this opportunity, please:

  1. Read the attached guidelines for concept proposals and the attached full announcement
  2. Send your concept proposal to by 11:59 p.m. PDT Monday, March 13, 2023.

After selection of the finalists, full proposals (research plan can be in draft form; budget and other business elements must be final) are due by Monday, April 3, and research plan must be final by Tuesday, April 11.

Please contact with any questions and forward this on to any investigators who you think might be eligible.